Search
‘We now know our enemy’: UBC study offers new hope for treating relapsed childhood leukemia
- OPACC
- Feb 8, 2024
- 1 min read
New therapies have dramatically improved survival rates among children with pediatric acute myeloid leukemia (pAML)—a cancer that starts in the blood-forming cells of the bone marrow. But in cases where the cancer returns, doctors, children and their families are faced with a new set of challenges.
Recent Posts
See AllQuality of life improvements can be made if clinicians better understand auditory attention decay after cancer treatment in pediatric...
A team of experts, issuing a statement on behalf of the American Heart Association, have detailed cardiometabolic considerations for...
While the overall prevalence of comorbidities at diagnosis in pediatric patients with acute lymphoblastic leukemia (ALL) and...
Comments